Zhengye Biotechnology Holding Limited ^ZYBT

Finances

	2024	2023	2022	2021
Revenue	186.356 M ^{-11.95 %}	211.651 M ^{-18.68 %}	260.269 M ^{21.58 %}	214.067 M
Net income	11.311 M ^{-64.04 %}	31.457 M ^{-32.69 %}	46.735 M ^{19.96 %}	38.959 M
Income before tax	14.394 M ^{-67.11 %}	43.762 M ^{-31.53 %}	63.914 M ^{20.44 %}	53.066 M
Income before tax ratio	0.08 ^{-62.64 %}	0.21 ^{-15.80 %}	0.25 ^{-0.94 %}	0.25
EBITDA	42.600 M ^{-40.91 %}	72.097 M ^{-15.73 %}	85.553 M ^{22.00 %}	70.124 M
Net income ratio	0.06 ^{-59.16 %}	0.15 ^{-17.23 %}	0.18 ^{-1.34 %}	0.18
Ratio EBITDA	0.23 ^{-32.89 %}	0.34 ^{3.63 %}	0.33 ^{0.35 %}	0.33
Gross profit ratio	0.49 ^{-20.15 %}	0.61 ^{4.02 %}	0.59 ^{0.70 %}	0.59
Weighted average shs out dil	0.000	0.000	0.000	0.000
Weighted average shs out	0.000	0.000	0.000	0.000
EPS diluted	0.00	0.00	0.00	0.00
Earnings per share	0.00	0.00	0.00	0.00
Gross profit	91.295 M ^{-29.69 %}	129.855 M ^{-15.41 %}	153.519 M ^{22.43 %}	125.393 M
Income tax expense	924.000 K ^{-85.22 %}	6.253 M ^{-23.48 %}	8.172 M ^{23.84 %}	6.599 M
Cost of revenue	95.061 M ^{16.22 %}	81.796 M ^{-23.38 %}	106.750 M ^{20.38 %}	88.674 M
General and administrative expenses	22.575 M ^{-12.81 %}	25.891 M ^{-10.70 %}	28.993 M ^{30.07 %}	22.290 M
Selling and marketing expenses	41.269 M ^{1.29 %}	40.743 M ^{17.87 %}	34.565 M ^{-3.73 %}	35.904 M
Other expenses	-1.782 M ^{-128.13 %}	6.334 M ^{-40.82 %}	10.703 M ^{210.59 %}	3.446 M
Operating expenses	74.856 M ^{-11.80 %}	84.869 M ^{-3.21 %}	87.685 M ^{20.10 %}	73.010 M
Cost and expenses	169.917 M ^{1.95 %}	166.665 M ^{-14.28 %}	194.435 M ^{20.26 %}	161.684 M
Research and development expenses	12.794 M ^{7.50 %}	11.901 M ^{-11.35 %}	13.424 M ^{18.07 %}	11.370 M
Selling general and administrative expenses	63.844 M ^{-4.19 %}	66.634 M ^{4.84 %}	63.558 M ^{9.22 %}	58.194 M
Interest income	231.000 K ^{-25.96 %}	312.000 K ^{173.68 %}	114.000 K ^{1.79 %}	112.000 K
Interest expense	4.043 M ^{-8.59 %}	4.423 M ^{55.79 %}	2.839 M ^{171.41 %}	1.046 M
Depreciation and amortization	24.163 M ^{1.05 %}	23.912 M ^{27.19 %}	18.800 M ^{17.41 %}	16.012 M
Operating income	16.439 M ^{-63.46 %}	44.986 M ^{-31.67 %}	65.834 M ^{25.68 %}	52.383 M
Operating income ratio	0.09 ^{-58.50 %}	0.21 ^{-15.97 %}	0.25 ^{3.37 %}	0.24
Total other income expenses net	-2.045 M ^{-67.08 %}	-1.224 M ^{36.25 %}	-1.920 M ^{-381.11 %}	683.000 K
	2024	2023	2022	2021

	2024	2023	2022	2021
Net debt	67.829 M ^{-9.29 %}	74.777 M ^{35.63 %}	55.134 M ^{132.48 %}	23.716 M
Total investments	1.433 M ^{17.08 %}	1.224 M	0.000	0.000
Total debt	86.433 M ^{-3.80 %}	89.850 M ^{38.49 %}	64.880 M ^{116.27 %}	30.000 M
Accumulated other comprehensive income loss	32.650 M ^{4.28 %}	31.311 M ^{13.59 %}	27.565 M ^{25.35 %}	21.991 M
Retained earnings	48.151 M ^{25.46 %}	38.381 M ^{-41.65 %}	65.774 M ^{55.40 %}	42.325 M
Common stock	8.000 K ^{0.00 %}	8.000 K ^{0.00 %}	8.000 K ^{0.00 %}	8.000 K
Total equity	352.540 M ^{3.91 %}	339.272 M ^{-4.93 %}	356.867 M ^{11.93 %}	318.837 M
Other non current liabilities	0.000 ^{-100.00 %}	393.000 K ^{-33.39 %}	590.000 K ^{-27.70 %}	816.000 K
Long term debt	4.800 M ^{-51.95 %}	9.990 M ^{0.00 %}	9.990 M	0.000
Total non current liabilities	4.800 M ^{-53.77 %}	10.383 M ^{-1.86 %}	10.580 M ^{1 196.57 %}	816.000 K
Other current liabilities	5.563 M ^{-69.82 %}	18.434 M ^{447.98 %}	3.364 M ^{-51.74 %}	6.970 M
Deferred revenue	3.685 M ^{-7.53 %}	3.985 M ^{-15.23 %}	4.701 M ^{9.73 %}	4.284 M
Short term debt	81.633 M ^{2.22 %}	79.860 M ^{45.49 %}	54.890 M ^{82.97 %}	30.000 M
Total current liabilities	135.907 M ^{-9.54 %}	150.233 M ^{-1.31 %}	152.227 M ^{21.17 %}	125.626 M
Total liabilities	140.707 M ^{-12.40 %}	160.616 M ^{-1.35 %}	162.807 M ^{28.76 %}	126.442 M
Other non current assets	26.746 M ^{311.22 %}	6.504 M ^{191.14 %}	2.234 M ^{-83.04 %}	13.170 M
Long term investments	0.000	0.000	0.000	0.000
Intangible assets	22.780 M ^{39.78 %}	16.297 M ^{-16.25 %}	19.458 M ^{61.49 %}	12.049 M
GoodWill	0.000	0.000	0.000	0.000
Goodwill and intangible assets	22.780 M ^{39.78 %}	16.297 M ^{-16.25 %}	19.458 M ^{61.49 %}	12.049 M
Property plant equipment net	255.164 M ^{-6.02 %}	271.495 M ^{-4.29 %}	283.674 M ^{11.19 %}	255.116 M
Total non current assets	315.681 M ^{7.27 %}	294.296 M ^{-3.63 %}	305.366 M ^{8.93 %}	280.335 M
Other current assets	10.790 M ^{-65.83 %}	31.574 M ^{112.08 %}	14.888 M ^{15.85 %}	12.851 M
Short term investments	1.433 M ^{17.08 %}	1.224 M	0.000	0.000
cash and cash equivalents	18.604 M ^{23.43 %}	15.073 M ^{54.66 %}	9.746 M ^{55.09 %}	6.284 M
Cash and short term investments	20.037 M ^{22.95 %}	16.297 M ^{67.22 %}	9.746 M ^{55.09 %}	6.284 M
Total current assets	177.566 M ^{-13.63 %}	205.592 M ^{-4.07 %}	214.308 M ^{29.93 %}	164.944 M
Inventory	58.220 M ^{-0.14 %}	58.300 M ^{5.19 %}	55.424 M ^{27.06 %}	43.622 M
Net receivables	88.519 M ^{-10.97 %}	99.421 M ^{-25.94 %}	134.250 M ^{31.38 %}	102.187 M
Tax assets	10.991 M	0.000	0.000	0.000
Other assets	0.000	0.000	0.000	0.000
Account payables	42.960 M ^{-5.91 %}	45.659 M ^{-42.41 %}	79.276 M ^{2.20 %}	77.566 M
Tax payables	2.066 M ^{-9.98 %}	2.295 M ^{-77.04 %}	9.996 M ^{46.87 %}	6.806 M
Deferred revenue non current	0.000	0.000	0.000	0.000
Minority interest	68.581 M ^{3.25 %}	66.422 M ^{10.02 %}	60.370 M ^{17.54 %}	51.363 M
Capital lease obligations	0.000	0.000	0.000	0.000
Preferred stock	0.000	0.000	0.000	0.000
Other total stockholders equity	203.150 M ^{0.00 %}	203.150 M ^{0.00 %}	203.150 M ^{0.00 %}	203.150 M
Deferred tax liabilities non current	0.000	0.000	0.000	0.000
Other liabilities	0.000	0.000	0.000	0.000
Total assets	493.247 M ^{-1.33 %}	499.888 M ^{-3.81 %}	519.674 M ^{16.71 %}	445.279 M
	2024	2023	2022	2021

	2024	2023	2022	2021
Deferred income tax	924.000 K ^{21.90 %}	758.000 K ^{169.29 %}	-1.094 M ^{-205.59 %}	-358.000 K
Stock based compensation	0.000	0.000	0.000	0.000
Change in working capital	-977.000 K ^{95.23 %}	-20.494 M ^{69.33 %}	-66.816 M ^{-98.21 %}	-33.709 M
Accounts receivables	11.310 M ^{-70.28 %}	38.053 M ^{180.32 %}	-47.378 M ^{-15.82 %}	-40.905 M
Inventory	-5.882 M ^{54.41 %}	-12.902 M ^{-4.68 %}	-12.325 M ^{0.15 %}	-12.343 M
Accounts payables	-404.000 K ^{98.87 %}	-35.613 M ^{-268.17 %}	-9.673 M ^{-154.86 %}	17.633 M
Other working capital	-6.001 M ^{40.18 %}	-10.032 M ^{-491.88 %}	2.560 M ^{34.31 %}	1.906 M
Other non cash items	3.466 M ^{-46.67 %}	6.499 M ^{-39.28 %}	10.703 M ^{215.26 %}	3.395 M
Net cash provided by operating activities	41.046 M ^{-14.81 %}	48.184 M ^{177.96 %}	17.335 M ^{-45.50 %}	31.807 M
Investments in property plant and equipment	-13.587 M ^{-83.71 %}	-7.396 M ^{72.94 %}	-27.328 M ^{-43.38 %}	-19.060 M
Acquisitions net	0.000	0.000	0.000	0.000
Purchases of investments	0.000 ^{100.00 %}	-1.224 M	0.000	0.000
Sales maturities of investments	0.000	0.000	0.000	0.000
Other investing activites	-14.078 M ^{-347.63 %}	-3.145 M	0.000 ^{100.00 %}	-7.210 M
Net cash used for investing activites	-27.665 M ^{-135.15 %}	-11.765 M ^{56.95 %}	-27.328 M ^{-4.03 %}	-26.270 M
Debt repayment	-2.738 M ^{-110.97 %}	24.970 M ^{-28.41 %}	34.880 M ^{336.00 %}	8.000 M
Common stock issued	0.000	0.000	0.000	0.000
Common stock repurchased	0.000	0.000	0.000	0.000
Dividends paid	-16.023 M ^{59.39 %}	-39.452 M ^{-84.14 %}	-21.425 M ^{-93.93 %}	-11.048 M
Other financing activites	-3.368 M ^{25.11 %}	-4.497 M	0.000	0.000
Net cash used provided by financing activities	-22.129 M ^{-16.60 %}	-18.979 M ^{-241.06 %}	13.455 M ^{541.44 %}	-3.048 M
Effect of forex changes on cash	168.000 K	0.000	0.000	0.000
Net change in cash	-8.580 M ^{-149.20 %}	17.440 M ^{403.76 %}	3.462 M ^{39.09 %}	2.489 M
Cash at beginning of period	27.186 M ^{178.95 %}	9.746 M ^{55.09 %}	6.284 M ^{65.59 %}	3.795 M
Cash at end of period	18.606 M ^{-31.56 %}	27.186 M ^{178.95 %}	9.746 M ^{55.09 %}	6.284 M
Operating cash flow	41.046 M ^{-14.81 %}	48.184 M ^{177.96 %}	17.335 M ^{-45.50 %}	31.807 M
Capital expenditure	-27.773 M ^{-139.42 %}	-11.600 M ^{57.55 %}	-27.328 M ^{-3.52 %}	-26.398 M
Free CashFlow	13.273 M ^{-63.72 %}	36.584 M ^{466.10 %}	-9.993 M ^{-284.75 %}	5.409 M
	2024	2023	2022	2021


Revenue
Net income
Income before tax
Income before tax ratio
EBITDA
Net income ratio
Ratio EBITDA
Gross profit ratio
Weighted average shs out dil
Weighted average shs out
EPS diluted
Earnings per share
Gross profit
Income tax expense
Cost of revenue
General and administrative expenses
Selling and marketing expenses
Other expenses
Operating expenses
Cost and expenses
Research and development expenses
Selling general and administrative expenses
Interest income
Interest expense
Depreciation and amortization
Operating income
Operating income ratio
Total other income expenses net

	2024-12-31	2024-06-30	2023-12-31	2023-06-30	2022-12-31
Net debt	67.829 M ^{-15.42 %}	80.198 M ^{7.25 %}	74.777 M ^{12.76 %}	66.316 M ^{20.28 %}	55.134 M
Total investments	1.433 M ^{8.15 %}	1.325 M ^{8.25 %}	1.224 M	0.000	0.000
Total debt	86.433 M ^{-1.10 %}	87.390 M ^{-2.74 %}	89.850 M ^{0.00 %}	89.850 M ^{38.49 %}	64.880 M
Accumulated other comprehensive income loss	32.650 M ^{4.27 %}	31.314 M ^{0.01 %}	31.311 M ^{13.59 %}	27.565 M ^{0.00 %}	27.565 M
Retained earnings	48.151 M ^{2.04 %}	47.187 M ^{22.94 %}	38.381 M ^{24.41 %}	30.851 M ^{-53.10 %}	65.774 M
Common stock	8.000 K ^{0.00 %}	8.000 K ^{0.00 %}	8.000 K ^{0.00 %}	8.000 K ^{0.00 %}	8.000 K
Total equity	352.540 M ^{0.78 %}	349.795 M ^{3.10 %}	339.272 M ^{4.12 %}	325.833 M ^{-8.70 %}	356.867 M
Other non current liabilities	0.000 ^{-100.00 %}	393.000 K ^{0.00 %}	393.000 K ^{-33.39 %}	590.000 K ^{0.00 %}	590.000 K
Long term debt	4.800 M	0.000 ^{-100.00 %}	9.990 M ^{0.00 %}	9.990 M ^{0.00 %}	9.990 M
Total non current liabilities	4.800 M ^{1 121.37 %}	393.000 K ^{-96.21 %}	10.383 M ^{-1.86 %}	10.580 M ^{0.00 %}	10.580 M
Other current liabilities	5.563 M ^{321.44 %}	1.320 M ^{-92.84 %}	18.434 M ^{-54.83 %}	40.813 M ^{1 113.23 %}	3.364 M
Deferred revenue	3.685 M ^{14.51 %}	3.218 M ^{-19.25 %}	3.985 M ^{-14.04 %}	4.636 M ^{-1.38 %}	4.701 M
Short term debt	81.633 M ^{-6.59 %}	87.390 M ^{9.43 %}	79.860 M ^{0.00 %}	79.860 M ^{45.49 %}	54.890 M
Total current liabilities	135.907 M ^{-1.11 %}	137.426 M ^{-8.52 %}	150.233 M ^{-15.32 %}	177.417 M ^{16.55 %}	152.227 M
Total liabilities	140.707 M ^{2.10 %}	137.819 M ^{-14.19 %}	160.616 M ^{-14.56 %}	187.997 M ^{15.47 %}	162.807 M
Other non current assets	26.746 M ^{41.34 %}	18.923 M ^{190.94 %}	6.504 M ^{54.53 %}	4.209 M ^{88.41 %}	2.234 M
Long term investments	0.000	0.000	0.000	0.000	0.000
Intangible assets	22.780 M ^{-7.46 %}	24.616 M ^{51.05 %}	16.297 M ^{-8.47 %}	17.806 M ^{-8.49 %}	19.458 M
GoodWill	0.000	0.000	0.000	0.000	0.000
Goodwill and intangible assets	22.780 M ^{-7.46 %}	24.616 M ^{51.05 %}	16.297 M ^{-8.47 %}	17.806 M ^{-8.49 %}	19.458 M
Property plant equipment net	255.164 M ^{0.32 %}	254.343 M ^{-6.32 %}	271.495 M ^{-1.24 %}	274.898 M ^{-3.09 %}	283.674 M
Total non current assets	315.681 M ^{5.98 %}	297.882 M ^{1.22 %}	294.296 M ^{-0.88 %}	296.913 M ^{-2.77 %}	305.366 M
Other current assets	10.790 M ^{-55.73 %}	24.375 M ^{-22.80 %}	31.574 M ^{104.96 %}	15.405 M ^{3.47 %}	14.888 M
Short term investments	1.433 M ^{8.15 %}	1.325 M ^{8.25 %}	1.224 M	0.000	0.000
cash and cash equivalents	18.604 M ^{158.68 %}	7.192 M ^{-52.29 %}	15.073 M ^{-35.95 %}	23.534 M ^{141.47 %}	9.746 M
Cash and short term investments	20.037 M ^{135.26 %}	8.517 M ^{-47.74 %}	16.297 M ^{-30.75 %}	23.534 M ^{141.47 %}	9.746 M
Total current assets	177.566 M ^{-6.41 %}	189.732 M ^{-7.71 %}	205.592 M ^{-5.22 %}	216.917 M ^{1.22 %}	214.308 M
Inventory	58.220 M ^{-10.69 %}	65.191 M ^{11.82 %}	58.300 M ^{8.01 %}	53.977 M ^{-2.61 %}	55.424 M
Net receivables	88.519 M ^{-3.42 %}	91.649 M ^{-7.82 %}	99.421 M ^{-19.82 %}	124.001 M ^{-7.63 %}	134.250 M
Tax assets	10.991 M	0.000	0.000	0.000	0.000
Other assets	0.000	0.000	0.000	0.000	0.000
Account payables	42.960 M ^{3.16 %}	41.643 M ^{-8.80 %}	45.659 M ^{-6.73 %}	48.954 M ^{-38.25 %}	79.276 M
Tax payables	2.066 M ^{-46.41 %}	3.855 M ^{67.97 %}	2.295 M ^{-27.24 %}	3.154 M ^{-68.45 %}	9.996 M
Deferred revenue non current	0.000	0.000	0.000	0.000	0.000
Minority interest	68.581 M ^{0.65 %}	68.136 M ^{2.58 %}	66.422 M ^{3.37 %}	64.259 M ^{6.44 %}	60.370 M
Capital lease obligations	0.000	0.000	0.000	0.000	0.000
Preferred stock	0.000	0.000	0.000	0.000	0.000
Other total stockholders equity	203.150 M ^{0.00 %}	203.150 M ^{0.00 %}	203.150 M ^{0.00 %}	203.150 M ^{0.00 %}	203.150 M
Deferred tax liabilities non current	0.000	0.000	0.000	0.000	0.000
Other liabilities	0.000	0.000	0.000	0.000	0.000
Total assets	493.247 M ^{1.16 %}	487.614 M ^{-2.46 %}	499.888 M ^{-2.71 %}	513.830 M ^{-1.12 %}	519.674 M
	2024-12-31	2024-06-30	2023-12-31	2023-06-30	2022-12-31


Deferred income tax
Stock based compensation
Change in working capital
Accounts receivables
Inventory
Accounts payables
Other working capital
Other non cash items
Net cash provided by operating activities
Investments in property plant and equipment
Acquisitions net
Purchases of investments
Sales maturities of investments
Other investing activites
Net cash used for investing activites
Debt repayment
Common stock issued
Common stock repurchased
Dividends paid
Other financing activites
Net cash used provided by financing activities
Effect of forex changes on cash
Net change in cash
Cash at beginning of period
Cash at end of period
Operating cash flow
Capital expenditure
Free CashFlow

Date	Form 10K
2024	https://www.sec.gov/Archives/edgar/data/1975641/000121390025061202/ea0239163-20f_zhengye.htm
2023
2022
2021

Zhengye Biotechnology Holding Limited ZYBT

Finances

Zhengye Biotechnology Holding Limited ^ZYBT